Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis

BACKGROUND: The aim of this observational study is to investigate the efficacy and safety of two approved oral disease-modifying therapies (DMTs) in patients with remitting-relapsing multiple sclerosis (RRMS): dimethyl fumarate (DMF) vs. teriflunomide (TRF). METHODS: A total of 159 RRMS patients (82...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurol Res Int
Главные авторы: Nehzat, Nasim, Mirmosayyeb, Omid, Barzegar, Mahdi, Vosoughi, Reza, Fazeli, Erfane, Shaygannejad, Vahid
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8298169/
https://ncbi.nlm.nih.gov/pubmed/34336283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6679197
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы